A reasonable chance it could cause serious harm or death.
Presence of Particulate Matter: Product contaminated with particulate matter identified as glass and/or paraformaldehyde
| Brand name | PAPAVERINE HYDROCHLORIDE |
| Generic name | PAPAVERINE HYDROCHLORIDE |
| Active ingredient(s) | PAPAVERINE HYDROCHLORIDE |
| Distributed by / for | American Regent, Inc. |
| NDC | 0517-4002-01 |
| Full product label | Papaverine HCl Injection, USP, 60 mg/2 mL (30 mg/mL), packaged in a) 2mL Single-Dose Vial (NDC 0517-4002-01), and b) 25x2mL Single-Dose Vials (NDC 0517-4002-25), Rx Only, AMERICAN REGENT, INC., SHIRLEY, NY 11967. |
| Recalling firm | American Regent, Inc. |
| Distribution | Nationwide within the U.S |
| Quantity | 86,100 vials |
| Recall initiated | 2026-07-24 |
| Report date | 2026-08-26 |
| Recall completed | — |
| Recall number | D-0800-2026 |
| Classification | Class I |
| FDA status | Ongoing |
| Origin on file | Shirley NY United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗